Bank of New York Mellon’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,175
| Closed | -$11K | – | 4775 |
|
|
2022
Q1 | $11K | Hold |
2,175
| – | – | ﹤0.01% | 4638 |
|
|
2021
Q4 | $12K | Hold |
2,175
| – | – | ﹤0.01% | 4608 |
|
|
2021
Q3 | $24K | Hold |
2,175
| – | – | ﹤0.01% | 4491 |
|
|
2021
Q2 | $37K | Sell |
2,175
-14,784
| -87% | -$251K | ﹤0.01% | 4354 |
|
|
2021
Q1 | $446K | Buy |
16,959
+2,872
| +20% | +$75.5K | ﹤0.01% | 3744 |
|
|
2020
Q4 | $509K | Buy |
14,087
+408
| +3% | +$14.7K | ﹤0.01% | 3607 |
|
|
2020
Q3 | $484K | Buy |
13,679
+5,020
| +58% | +$178K | ﹤0.01% | 3504 |
|
|
2020
Q2 | $368K | Buy |
8,659
+6,197
| +252% | +$263K | ﹤0.01% | 3615 |
|
|
2020
Q1 | $196K | Buy |
2,462
+67
| +3% | +$5.33K | ﹤0.01% | 3739 |
|
|
2019
Q4 | $221K | Buy |
2,395
+329
| +16% | +$30.4K | ﹤0.01% | 3885 |
|
|
2019
Q3 | $156K | Sell |
2,066
-97
| -4% | -$7.32K | ﹤0.01% | 3946 |
|
|
2019
Q2 | $215K | Buy |
+2,163
| New | +$215K | ﹤0.01% | 3890 |
|
|
2016
Q3 | – | Sell |
-114
| Closed | -$10K | – | 4326 |
|
|
2016
Q2 | $10K | Buy |
+114
| New | +$10K | ﹤0.01% | 4291 |
|
|
2015
Q2 | – | Sell |
-278
| Closed | -$205K | – | 4289 |
|
|
2015
Q1 | $205K | Sell |
278
-4
| -1% | -$2.95K | ﹤0.01% | 3888 |
|
|
2014
Q4 | $190K | Buy |
+282
| New | +$190K | ﹤0.01% | 3897 |
|